Suchergebnisse - "Back, David J"

PubPharm (226)

1

Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

enthalten in: Clinical pharmacology and therapeutics | 2022

von Marzolini, C. | Kuritzkes, D. | Marra, F. | +9

CommentIn: Clin Pharmacol Ther. 2023 Apr;113(4):768-769. - PMID 36544259

2

Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics

enthalten in: bioRxiv.org | 2022

von Arshad, U. | Pertinez, H. | Box, H. | +18

3

Fluvoxamine for the treatment of COVID-19

enthalten in: The Lancet. Global health | 2022

von Marzolini, C. | Marra, F. | Boyle, A. | +2

CommentOn: Lancet Glob Health. 2022 Jan;10(1):e42-e51. - PMID 34717820

4

Dexamethasone is a dose-dependent perpetrator of drug-drug interactions : implications for use in people living with HIV

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Jacobs, T. | Marzolini, C. | Back, D. | +1

5

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Marzolini, C. | Kuritzkes, D. | Marra, F. | +9

6

Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID-19 Therapeutic Development

enthalten in: Clinical pharmacology and therapeutics | 2021

von Boffito, M. | Back, D. | Flexner, C. | +7

CommentIn: Clin Pharmacol Ther. 2021 Aug;110(2):294-296. - PMID 33410139

7

Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

enthalten in: Clinical pharmacokinetics | 2021

von Hodge, D. | Back, D. | Gibbons, S. | +2

8

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

enthalten in: Clinical pharmacokinetics | 2021

von Hodge, D. | Back, D. | Gibbons, S. | +2

9

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

enthalten in: Clinical pharmacokinetics | 2021

von Hodge, D. | Back, D. | Gibbons, S. | +2

10

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

enthalten in: Clinical pharmacokinetics | 2021

von Hodge, D. | Back, D. | Gibbons, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]